SANUWAVE Health Receives Nasdaq Notice of Possible Delisting

What Happened SANUWAVE Health, Inc. (SNWV) filed an 8‑K after receiving a notice from Nasdaq on September 23, 2026 that its Market Value of Listed Securities (MVLS) has been below the required $50,000,000 for the last 30 consecutive business days. The notice has no immediate effect on trading, but Nasdaq has given the company a 180‑calendar‑day compliance period (until March 22, 2027) to regain the minimum MVLS required for continued listing on The Nasdaq Global Market.

Key Details

• Nasdaq determined MVLS was below the $50,000,000 minimum required under Nasdaq Listing Rule 5450(b)(2)(A) for the prior 30 consecutive business days.
• Sanuwave has 180 calendar days from the notice date (through March 22, 2027) to regain compliance.
• Compliance is achieved if MVLS closes at $50,000,000 or more for at least 10 consecutive business days during the period; otherwise the company will be notified that its securities are subject to delisting.
• The company may alternatively seek transfer to The Nasdaq Capital Market if it meets those listing requirements.
• The filing includes a forward‑looking statements disclaimer; the 8‑K was signed by CEO Morgan C. Frank on September 25, 2026.

Why It Matters This notice signals a listing compliance risk that investors should monitor: failure to regain the $50M MVLS threshold could lead to delisting proceedings (or a transfer to a different Nasdaq tier). That outcome could reduce liquidity and market visibility for SNWV shares and affect the company’s ability to access capital. The company stated it will monitor MVLS and consider available options but gave no assurance it will maintain its Global Market listing.